Incidence and risk of high-grade stomatitis with mTOR inhibitors in cancer patients.
about
Treatment-related gastrointestinal toxicities and advanced colorectal or pancreatic cancer: A critical updatePhase I trial of MEK 1/2 inhibitor pimasertib combined with mTOR inhibitor temsirolimus in patients with advanced solid tumors.New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal InjuryNeoadjuvant chemotherapy (NCT) plus targeted agents versus NCT alone in colorectal liver metastases patients: A systematic review and meta-analysisOral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors.Discontinuation of Everolimus Due to Related and Unrelated Adverse Events in Cancer Patients: A Meta-Analysis.A prospective observational study on the evaluation of everolimus-related adverse events in metastatic renal cell carcinoma after first-line anti-vascular endothelial growth factor therapy: the AFINITE study in France.
P2860
Q26778004-D06C6D5A-786E-4620-AD54-482B47F6FF02Q33439312-95DCF325-6CED-4A46-96FA-08CAD9697E34Q33774917-C97AF49A-4405-4118-84E7-172A4BF01B08Q35826810-C73C5B1E-3ACC-41EB-8BFC-D28DAD80014FQ38948950-8417DFAF-6A26-4321-8916-2AFA42C04BB5Q48252794-8729B49A-E73E-4276-B62F-05502648C67EQ50898788-75F8B605-EEEA-4F76-A5F0-BAC93536E7A3
P2860
Incidence and risk of high-grade stomatitis with mTOR inhibitors in cancer patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Incidence and risk of high-grade stomatitis with mTOR inhibitors in cancer patients.
@en
Incidence and risk of high-grade stomatitis with mTOR inhibitors in cancer patients.
@nl
type
label
Incidence and risk of high-grade stomatitis with mTOR inhibitors in cancer patients.
@en
Incidence and risk of high-grade stomatitis with mTOR inhibitors in cancer patients.
@nl
prefLabel
Incidence and risk of high-grade stomatitis with mTOR inhibitors in cancer patients.
@en
Incidence and risk of high-grade stomatitis with mTOR inhibitors in cancer patients.
@nl
P2860
P1433
P1476
Incidence and risk of high-grade stomatitis with mTOR inhibitors in cancer patients.
@en
P2093
Raji Shameem
Shenhong Wu
P2860
P356
10.3109/07357907.2014.1001893
P577
2015-01-30T00:00:00Z